___
Svenska
Contact
About IRLAB
About IRLAB
Therapeutic focus
Therapeutic focus
Parkinson’s disease
Patient portrait
PD-LIDs
PD-Falls
Project portfolio
Project portfolio
Mesdopetam (IRL790)
Pirepemat (IRL752)
IRL942 & 1009
Discovery phase
Research platform
ISP platform
Scientific publications
Newsroom
Newsroom
Presentations & events
Press releases
Event calendar
Image library
Investors
Investors
Financial reports
The share
Owners
Share capital development
PDMR transactions
Analysts
Financial calendar
Listing Nasdaq Stockholm Main Market 2020
Rights issue Feb 2020
Initial public offering 2017
Corporate Governance
Corporate Governance
General Meetings
Annual General Meeting 2021
Previous general meetings
Corporate governance reports
Board of directors
Nomination committee
Nomination Committee for AGM 2021
Previous nomination committees
Management
Auditor
Remuneration
Certified advisor
Internal control
Diversity
Articles of association
Nicholas Waters, CEO, presents at Redeye’s Growth Day 2020
Share this:
Facebook
Twitter
Linkedin
June 2, 2020
In Swedish only.
IRLAB’s CEO presents at Redeyes Growth Day 2020 on June 2, 2020.
Watch here >
